KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Assets (2018 - 2025)

Bionano Genomics (BNGO) has disclosed Return on Assets for 8 consecutive years, with 0.35% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 103.0% to 0.35% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.35% through Dec 2025, up 103.0% year-over-year, with the annual reading at 0.35% for FY2025, 42.0% up from the prior year.
  • Return on Assets hit 0.35% in Q4 2025 for Bionano Genomics, up from 0.5% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.14% in Q2 2021 to a low of 1.42% in Q2 2024.
  • Historically, Return on Assets has averaged 0.67% across 5 years, with a median of 0.48% in 2023.
  • Biggest five-year swings in Return on Assets: skyrocketed 128bps in 2021 and later plummeted -90bps in 2024.
  • Year by year, Return on Assets stood at 0.2% in 2021, then crashed by -114bps to 0.42% in 2022, then crashed by -179bps to 1.17% in 2023, then decreased by -17bps to 1.37% in 2024, then surged by 75bps to 0.35% in 2025.
  • Business Quant data shows Return on Assets for BNGO at 0.35% in Q4 2025, 0.5% in Q3 2025, and 0.97% in Q2 2025.